drugset / Trial / NCT07657182

A Prospective, Randomized, Assessor-Blinded, Multicenter Study Comparing Avance Nerve Graft and Autograft for Functional Recovery Following Mixed and Motor Peripheral Nerve Reconstruction

NCT07657182 ↗

Phase 4 Recruiting 178 enrolled Axogen Corporation
RandomizedParallel-groupSingle-blindTreatment

Summary

This is a multicenter, 1:1 randomized, prospective, comparative study in participants requiring reconstruction of a mixed or motor nerve in the upper extremity. This study will consist of a screening visit, an operative visit, and 9 post-operative follow-up visits at Week 4, and Months 3, 6, 9, 12, 15, 18, 21, and 24.

Timeline

Start
2026-06-12
Primary completion
2030-12-05
Completion
2030-12-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Avance Nerve Graft Unknown — —